{"id":30,"date":"2007-02-20T20:29:49","date_gmt":"2007-02-20T20:29:49","guid":{"rendered":"http:\/\/www.the-finance-zone.co.uk\/?p=30"},"modified":"2007-02-20T20:29:49","modified_gmt":"2007-02-20T20:29:49","slug":"shire-snaps-up-us-partner-for-26bn","status":"publish","type":"post","link":"https:\/\/the-finance-zone.co.uk\/index.php\/2007\/02\/20\/shire-snaps-up-us-partner-for-26bn\/","title":{"rendered":"Shire snaps up US partner for $2.6bn"},"content":{"rendered":"<p><strong><a href=\"http:\/\/mwprices.ft.com\/custom\/ft2-com\/html-quotechartnews.asp?FTSite=FTCOM&#038;q=SHP&#038;searchtype&#038;expanded=&#038;countrycode=uk&#038;s2=uk&#038;symb=SHP&#038;company=NEW\"><font color=\"#003399\">Shire, <\/font><\/a><\/strong>the UK pharmaceuticals group, on Tuesday said it was paying $2.6bn in cash to acquire <strong><a href=\"http:\/\/mwprices.ft.com\/custom\/ft2-com\/html-quotechartnews.asp?FTSite=FTCOM&#038;q=NRPH&#038;searchtype&#038;expanded=&#038;countrycode=us&#038;s2=us&#038;symb=NRPH&#038;company=NEW\"><font color=\"#003399\">New River Pharmaceuticals<\/font><\/a><\/strong>, a US drugs group that specialises in treatments for attention deficit and hyperactivity disorder (ADHD), Shire\u00e2\u20ac\u2122s main market.<\/p>\n<p>The deal, which values New River at $64 a share, comes two years after Shire entered into a collaborative agreement with the US company to develop and co-promote an ADHD treatment known as Vyvanse. The US Food and Drug Administration is expected to approve the treatment by the end of this week.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shire, the UK pharmaceuticals group, on Tuesday said it was paying $2.6bn in cash to acquire New River Pharmaceuticals, a<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout","footnotes":""},"categories":[45],"tags":[],"class_list":["post-30","post","type-post","status-publish","format-standard","hentry","category-takeoversmergers"],"_links":{"self":[{"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/posts\/30","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/comments?post=30"}],"version-history":[{"count":0,"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/posts\/30\/revisions"}],"wp:attachment":[{"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/media?parent=30"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/categories?post=30"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/the-finance-zone.co.uk\/index.php\/wp-json\/wp\/v2\/tags?post=30"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}